Skip to content
Screener

Orthofix Medical Inc. OFIX D&A

Discontinued — last reported Q1 '25

D&A at other companies

Globus Medical logo
Globus MedicalGMED
$29.56M-2.1%
Alphatec Holdings logo
Alphatec HoldingsATEC
$3.92M-4.6%
Enovis logo
EnovisENOV
$41.56M-3.3%
Xtant Medical Holdings logo
Xtant Medical HoldingsXTNT
$508K-56.5%
Medtronic logo
MedtronicMDT
$716M-14.8%
Bioventus logo
BioventusBVS
$1.04M-27.7%

Segments

By segment

See full
Global Spine$9.99M-32.8%
Global Limb Reconstruction$2.81M—

Other financials

Income statement

See full
Revenue$210.9M+3.8%
Gross profit$149.7M+7.3%
Operating income-$8.1M+49.2%
Net income-$15.8M-12.2%
EPS (diluted)-$0.39-8.3%

Balance sheet

See full
Cash & equivalents$103.8M+58.2%
Total debt$237.7M+33.3%
Total equity$429.2M-6.4%
Total assets$873.0M+4.3%

Cash flow

See full
Operating cash flow-$6.2M-153%
CapEx$12.6M+77.9%
Free cash flow-$18.9M—

Valuation

See full
Market cap$417.92M-18.2%
Enterprise value$551.79M-11.5%
P/S0.5×-0.1×

Profitability

See full
Gross margin71.3%+3.9pp
Operating margin-4.8%-1.8pp
Net margin-7.4%-2.5pp
FCF margin-9.7%-1.8pp

Returns & leverage

See full
Return on equity-13.9%-4.2pp
Debt / equity0.6×+0.2×
Current ratio2.8×+0.2×

Where this comes from

Reported directly by Orthofix Medical Inc. in its filing.

Tagged under the XBRL concept us-gaap:DepreciationAndAmortization.

The source filing: Orthofix Medical Inc.’s 10-Q, filed May 6, 2025. Open the filing →

Filed
May 6, 2025
Fiscal quarter
Q1 FY2025
Calendar quarter
Q1 2025
Accession
0000950170-25-063956

FAQ

What is Orthofix Medical Inc.'s D&A?
Orthofix Medical Inc. (OFIX) reported D&A of $34.43M in Q1 2025.
How has Orthofix Medical Inc.'s D&A changed year-over-year?
Orthofix Medical Inc.'s D&A increased by 131.7% year-over-year, from $14.86M to $34.43M.
What is the long-term trend for Orthofix Medical Inc.'s D&A?
Over 3 years (2021 to 2024), Orthofix Medical Inc.'s D&A has grown at a 26.6% compound annual growth rate (CAGR), from $29.6M to $60.06M.
What does D&A mean?
Non-cash expense representing the systematic allocation of tangible asset costs (depreciation) and intangible asset costs (amortization) over their useful lives.

Ask your AI about Orthofix Medical Inc.'s d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude